Preclinical Neurology CRO | Pain, CNS, and Neurodegeneration Models

EXPERT PRECLINICAL SERVICES TAILORED TO YOUR RESEARCH NEEDS

At MD Biosciences, we recognize the transformative impact of your research in changing lives. Whether targeting CNS disorders, pain management, or wound healing, your therapies can revolutionize patient care. With over 30 years of expertise as a CRO, we offer insights and methodologies to enhance the clinical relevance of your preclinical data and accelerate your path to breakthrough treatments. Our collaborative efforts have advanced new drugs into the clinic and earned recognition in leading scientific publications.

State-of-the-art Facility for Translational Research

Our purpose-built GLP facility drives translational CNS research. It features dedicated spaces for rodent and pig studies, advanced neurophysiology, ex vivo biomarker analysis, in vivo electrophysiology, and fully equipped histology labs.

COMPREHENSIVE EXPERTISE IN KEY DISEASE AREAS

Our scientists excel in designing and executing complex studies across therapeutic areas. We deliver cutting-edge methodologies and key insights to maximize the value and clinical relevance of your research.

Leaders in Large Animal Models

MD Biosciences is at the forefront of developing translational pig models, pioneering advanced methodologies and novel quantitative measures to de-risk clinical trials and drive success in neuroscience and pain research.

Learn More

4-6

Week lead time

80+

Customizable models

30+

Expert scientists

20+

Publications

TRUSTED PRECLINICAL PARTNER

Dedicated to building lasting partnerships, we function as an extended team, leveraging our deep expertise and collaborative approach to drive complex drug development.

MDB Team

Throughout the past 15 years, MD Biosciences has provided an unsurpassed level of professional service, timely study conduct, and thorough study reports. There has also been a generous amount of dialogue and advice provided to us by their expert scientists and staff. MD Biosciences has without question been our most important nonclinical pharmacology service provider.

We have established a robust relationship with MD Biosciences in various capacities and studies over the past 15 years. Their analysis demonstrates the breadth and expertise as well as the ability to deliver results in a timely manner and with great confidence.

I work extensively with CROs and have found MD Biosciences incredibly easy to work with. I am immensely impressed with the dedication to the experiment, and their intimate knowledge of behavioral pharmacology. I believe the high quality data I receive is run in the most rigorous manner and key decisions have been made internally with data collected at MD Biosciences.